OTCMKTS:PURE - Pure Bioscience, Inc. Common Stock Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.67 -0.01 (-1.47 %)
(As of 06/20/2018 12:04 PM ET)
Previous Close$0.6750
Today's Range$0.65 - $0.70
52-Week Range$0.55 - $1.36
Volume17,250 shs
Average Volume22,392 shs
Market Capitalization$44.39 million
P/E Ratio-6.70
Dividend YieldN/A
Beta-1.28
Pure Bioscience, Inc. Common Stock logoPURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a antimicrobial food processing aid for use in poultry processing and produce processing; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PURE
CUSIPN/A
Phone619-596-8600

Debt

Debt-to-Equity RatioN/A
Current Ratio2.60
Quick Ratio2.16

Price-To-Earnings

Trailing P/E Ratio-6.70
Forward P/E Ratio-6.09
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.83 million
Price / Sales24.93
Cash FlowN/A
Price / CashN/A
Book Value$0.03 per share
Price / Book22.33

Profitability

EPS (Most Recent Fiscal Year)($0.10)
Net Income$-6,260,000.00
Net Margins-444.05%
Return on Equity-280.28%
Return on Assets-200.23%

Miscellaneous

Employees13
Outstanding Shares68,080,000

Pure Bioscience, Inc. Common Stock (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience, Inc. Common Stock's stock symbol?

Pure Bioscience, Inc. Common Stock trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience, Inc. Common Stock's earnings last quarter?

Pure Bioscience, Inc. Common Stock (OTCMKTS:PURE) released its quarterly earnings data on Wednesday, June, 13th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.02). The firm earned $0.39 million during the quarter, compared to analysts' expectations of $1 million. Pure Bioscience, Inc. Common Stock had a negative return on equity of 280.28% and a negative net margin of 444.05%. View Pure Bioscience, Inc. Common Stock's Earnings History.

When is Pure Bioscience, Inc. Common Stock's next earnings date?

Pure Bioscience, Inc. Common Stock is scheduled to release their next quarterly earnings announcement on Thursday, October, 25th 2018. View Earnings Estimates for Pure Bioscience, Inc. Common Stock.

Who are some of Pure Bioscience, Inc. Common Stock's key competitors?

Who are Pure Bioscience, Inc. Common Stock's key executives?

Pure Bioscience, Inc. Common Stock's management team includes the folowing people:
  • Mr. David J. Pfanzelter, Chairman (Age 65)
  • Mr. Henry R. Lambert, CEO & Director (Age 67)
  • Mr. Mark Stuart Elliott, Principal Financial & Accounting Officer and VP of Fin. (Age 43)
  • Mr. Gary L. Primes, VP of Operations
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

Has Pure Bioscience, Inc. Common Stock been receiving favorable news coverage?

Press coverage about PURE stock has trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pure Bioscience, Inc. Common Stock earned a news impact score of 0.15 on Accern's scale. They also gave media stories about the company an impact score of 46.35 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Pure Bioscience, Inc. Common Stock?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pure Bioscience, Inc. Common Stock's stock price today?

One share of PURE stock can currently be purchased for approximately $0.67.

How big of a company is Pure Bioscience, Inc. Common Stock?

Pure Bioscience, Inc. Common Stock has a market capitalization of $44.39 million and generates $1.83 million in revenue each year. The company earns $-6,260,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Pure Bioscience, Inc. Common Stock employs 13 workers across the globe.

How can I contact Pure Bioscience, Inc. Common Stock?

Pure Bioscience, Inc. Common Stock's mailing address is 1725 GILLESPIE WAY, EL CAJON CA, 92020. The company can be reached via phone at 619-596-8600.


MarketBeat Community Rating for Pure Bioscience, Inc. Common Stock (PURE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience, Inc. Common Stock and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.